G.  Subramanian, ?Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules?, mSphere, vol. 3, no. 1, pp.  e00534-17, 2018.

B.  Subramani, Shantamurthy, C. D., Maru, P., Belekar, M. A., Mardhekar, S., Shanmugam, D., and Kikkeri, R., ?Demystifying a hexuronic acid ligand that recognizes Toxoplasma gondii and blocks its invasion into host cells?, Organic & Biomolecular Chemistry, vol. 17, no. 18, pp. 4535-4542, 2019.

G.  Subramanian, Belekar, M. A., Shukla, A., Tong, J. Xin, Sinha, A., Chu, T. T. T., Kulkarni, A. S., Preiser, P. R., D. Reddy, S., Tan, K. S. W., Shanmugam, D., and Chandramohanadas, R., ?Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules (vol 3, e00534-17, 2018)?, MSphere, vol. 4, no. 2, pp. e00159-19, 2019.

A. Tanala Patra, Hingamire, T., Belekar, M. A., Xiong, A., Subramanian, G., Bozdech, Z., Preiser, P., Shanmugam, D., and Chandramohanadas, R., ?Whole-cell phenotypic screening of medicines for malaria venture pathogen box identifies specific inhibitors of plasmodium falciparum late-stage development and egress?, Antimicrobial Agents and Chemotherapy, vol. 64, no. 5, pp. e01802-19, 2020.